MEDICAL LETTER ON DRUGS AND THERAPEUTICS

Scope & Guideline

Informed Decisions for Optimal Drug Therapy

Introduction

Welcome to the MEDICAL LETTER ON DRUGS AND THERAPEUTICS information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of MEDICAL LETTER ON DRUGS AND THERAPEUTICS, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0025-732x
PublisherMED LETTER INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1965 to 2024
AbbreviationMED LETT DRUGS THER / Med. Lett. Drugs Ther.
Frequency26 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address145 HUGUENOT ST, SUITE 312, NEW ROCHELLE, NY 10801-7537

Aims and Scopes

The journal "Medical Letter on Drugs and Therapeutics" focuses on providing concise, evidence-based information about medications and their therapeutic uses. Its primary aim is to assist healthcare professionals in making informed decisions regarding drug therapy.
  1. Drug Evaluation and Comparison:
    The journal evaluates new drugs, comparing them to existing therapies, and highlighting their efficacy, safety, and cost-effectiveness.
  2. Updates on Therapeutics:
    It provides ongoing updates regarding new therapeutic indications, formulations, and clinical guidelines for various drug classes.
  3. Public Health and Vaccination:
    The journal emphasizes public health initiatives, particularly in vaccination strategies, and the management of infectious diseases.
  4. Clinical Guidelines and Recommendations:
    It offers practical clinical guidelines and recommendations based on the latest evidence and consensus in the field of pharmacotherapy.
  5. Continuing Medical Education (CME):
    The journal incorporates CME components to ensure healthcare professionals remain updated on the latest developments in drug therapy.
The journal has identified several emerging themes in drug therapy that reflect current healthcare challenges and advancements in pharmacotherapy. These themes are increasingly relevant to clinicians and researchers alike.
  1. Vaccination and Preventative Therapies:
    There is a growing emphasis on vaccination, particularly in light of the COVID-19 pandemic, with numerous articles focusing on new vaccine formulations and their therapeutic applications.
  2. Gene and Cell Therapies:
    The journal is increasingly covering innovative gene and cell therapies, highlighting breakthroughs in the treatment of genetic disorders and certain cancers.
  3. Biologics and Targeted Therapies:
    A significant trend towards biologics and targeted therapies in various fields, including oncology and immunology, indicates a shift in treatment paradigms.
  4. Mental Health and Depression Treatments:
    With rising mental health concerns, there is an increasing number of articles focused on new treatment options for depression and anxiety disorders.
  5. Digital Health and Telemedicine:
    The integration of digital health technologies and telemedicine in drug therapy has emerged as a relevant topic, reflecting the changes in healthcare delivery models.

Declining or Waning

In recent years, certain therapeutic areas and topics have seen a decline in coverage within the journal. This shift may reflect changes in clinical focus or advancements in therapeutic options.
  1. Long-term Chronic Disease Management:
    There has been a noticeable decline in articles focused on chronic disease management strategies, possibly due to the increasing emphasis on novel therapies and acute interventions.
  2. Traditional Antibiotics:
    Coverage of traditional antibiotics has waned, likely due to the rise of resistance issues and the introduction of novel agents that overshadow older drugs.
  3. Over-the-Counter (OTC) Medications:
    The frequency of articles discussing OTC medications has decreased, which may indicate a shift towards prescription-only therapies as primary treatment options.
  4. Pain Management with Opioids:
    As the opioid crisis continues, there has been a reduction in articles focusing on opioid therapies, reflecting a broader trend toward non-opioid pain management.
  5. Psychiatric Drug Treatments:
    The journal has seen a decrease in the number of articles specifically addressing traditional psychiatric medications, possibly due to a shift toward newer treatment modalities and therapies.

Similar Journals

BIOMEDICAL PAPERS-OLOMOUC

Catalyzing insights in molecular biology and medicine.
Publisher: PALACKY UNIV, MEDICAL FACISSN: 1213-8118Frequency: 4 issues/year

BIOMEDICAL PAPERS-OLOMOUC, published by Palacky University Medical Faculty, is a prominent open-access journal dedicated to advancing the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 2001, this journal has provided a vital platform for researchers, professionals, and students alike, fostering a collaborative environment for the dissemination of cutting-edge research findings. With a current impact factor reflected in its placement in the Q3 quartiles for both biochemistry and medicine categories, it demonstrates a growing influence in the academic community. The journal is indexed in Scopus, showcasing its relevance within the medical and biophysical sciences, and it operates in an open-access format to ensure broad accessibility of its articles. Set against the backdrop of Olomouc, Czech Republic, BIOMEDICAL PAPERS-OLOMOUC continues to contribute significantly to the global dialogue in biomedical research, making it an essential resource for anyone engaged in these dynamic and rapidly evolving fields.

CLINICAL THERAPEUTICS

Pioneering the future of drug development and clinical practice.
Publisher: ELSEVIERISSN: 0149-2918Frequency: 12 issues/year

Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.

CURRENT PHARMACEUTICAL DESIGN

Innovating Drug Discovery, Shaping Tomorrow's Therapies
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1381-6128Frequency: 46 issues/year

CURRENT PHARMACEUTICAL DESIGN is a leading journal in the fields of Drug Discovery and Pharmacology, published by Bentham Science Publishers Ltd in the dynamic United Arab Emirates. With an impressive historical span from 1995 to 2024, this journal serves as a vital platform for disseminating innovative research findings, breakthrough methodologies, and critical reviews that shape the future of pharmaceutical sciences. Ranked Q2 in both Drug Discovery and Pharmacology categories according to the 2023 metrics, it places itself within the top-tier percentile, catering to a diverse audience of researchers, industry professionals, and students. The journal’s commitment to high-quality research exploration is evidenced by its Scopus ranking, where it is positioned favorably within its category ranks. Although currently not Open Access, CURRENT PHARMACEUTICAL DESIGN remains an essential resource for those looking to stay at the forefront of pharmacological advancements and drug development strategies.

FUNDAMENTAL & CLINICAL PHARMACOLOGY

Pioneering insights in pharmacology since 1987.
Publisher: WILEYISSN: 0767-3981Frequency: 6 issues/year

FUNDAMENTAL & CLINICAL PHARMACOLOGY is a distinguished journal dedicated to advancing the fields of pharmacology and clinical medicine. Published by WILEY, this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike to disseminate innovative research findings and clinical applications. With an impressive history spanning from 1987 to 2024, it has consistently maintained its relevance in the scientific community, evidenced by its Q2 quartile ranking in both Pharmacology and Pharmacology (medical) categories for 2023. The journal's diverse publication range, which includes original research articles, reviews, and clinical studies, helps bridge the gap between fundamental research and practical application in healthcare settings. Although it does not offer open access, its rigorous peer-review process ensures that published content meets the highest scholarly standards, making it a vital resource for those aiming to stay at the forefront of pharmacological sciences.

Clinical Pharmacology in Drug Development

Advancing pharmaceutical science for a healthier tomorrow.
Publisher: WILEYISSN: 2160-7648Frequency: 6 issues/year

Clinical Pharmacology in Drug Development, published by WILEY, is a distinguished journal dedicated to advancing the field of pharmaceutical science and drug development. With a strong commitment to disseminating cutting-edge research, this journal serves as a crucial platform for professionals, researchers, and students aiming to enhance their understanding of pharmacological principles and innovations in medical therapeutics. Since its inception in 2012, the journal has consistently maintained a noteworthy presence in the academic community, currently achieving a Q2 ranking in both Pharmaceutical Science and Medical Pharmacology categories as of 2023. Although the journal operates under a subscription model, it is highly regarded for its rigorous peer-reviewed publications, offering insights into drug efficacy, safety, and regulatory challenges. Positioned at the intersection of clinical practices and pharmaceutical advancements, Clinical Pharmacology in Drug Development plays an essential role in bridging the gap between scientific research and real-world application, ensuring that the latest therapeutic strategies are optimized for patient care.

TRENDS IN PHARMACOLOGICAL SCIENCES

Navigating Innovations in Pharmacology and Toxicology
Publisher: CELL PRESSISSN: 0165-6147Frequency: 12 issues/year

TRENDS IN PHARMACOLOGICAL SCIENCES, an esteemed journal published by CELL PRESS, is a leading platform in the field of pharmacology and toxicology, with an impressive history since its inception in 1979. With an impact factor that places it in the top quartile category (Q1) for both pharmacology and toxicology as of 2023, it is recognized for disseminating high-quality, peer-reviewed research that shapes the future of these disciplines. The journal is indexed with a robust standing in Scopus rankings, positioned at rank #2 in Toxicology and #6 in Pharmacology, both boasting an extraordinary percentile of 98. Researchers, professionals, and students benefit from its comprehensive coverage, which spans cutting-edge advancements, review articles, and significant trends in drug development and toxicity assessment. While the journal does not currently offer open access options, it remains a vital resource for the academic community, ensuring critical insights into the complexities of pharmacological sciences are readily available to enhance research and practice.

Biuletyn Wydzialu Farmaceutycznego Warszawskiego Uniwersytetu Medycznego

Exploring New Frontiers in Pharmaceutical Sciences
Publisher: MEDICAL UNIV WARSAWISSN: 2080-1602Frequency:

Biuletyn Wydzialu Farmaceutycznego Warszawskiego Uniwersytetu Medycznego is a prestigious academic journal dedicated to publishing high-quality research in the field of pharmaceutical sciences. Published by the Medical University of Warsaw, this journal serves as a vital platform for researchers, professionals, and students to share their findings and advances in drug development, pharmaceutical sciences, and clinical practices. With its ISSN 2080-1602, it upholds rigorous standards of academic integrity and relevance to the pharmaceutical community. Although it currently does not offer open access, the journal plays a crucial role in disseminating knowledge, contributing to the advancement of pharmacy and health sciences. Located in Warsaw, Poland, it aims to bridge gaps in pharmaceutical research and practice, fostering collaboration and innovation among professionals in the field.

New Armenian Medical Journal

Shaping the Future of Medicine Through Rigorous Research.
Publisher: YEREVAN STATE MEDICAL UNIVISSN: 1829-0825Frequency: 4 issues/year

New Armenian Medical Journal (ISSN: 1829-0825, E-ISSN: 1829-0825) is a prominent academic publication established by Yerevan State Medical University, dedicated to advancing the field of medicine through high-quality research and scholarly discourse. Located in Armenia, this journal serves as a vital platform for disseminating innovative findings and clinical practices, with a particular focus on the regional healthcare landscape as well as global health issues. While currently categorized in the lower quartile (Q4) of general medicine, it demonstrates a commitment to improving its impact factor and ranking, evidenced by its ongoing publication from 2009 to 2024. The journal embraces a diverse scope that encompasses miscellaneous topics within medical research, catering to the needs of practitioners, researchers, and students alike. Though not an open-access journal, it offers valuable insights and knowledge that contribute meaningfully to the medical community. By participating in this scholarly dialogue, readers can enhance their understanding and foster advancements in the ever-evolving field of medicine.

CLINICAL PHARMACOLOGY & THERAPEUTICS

Exploring the future of drug therapy and pharmacokinetics.
Publisher: WILEYISSN: 0009-9236Frequency: 6 issues/year

CLINICAL PHARMACOLOGY & THERAPEUTICS, published by WILEY, stands at the forefront of pharmacological research, serving as a pivotal resource for researchers, healthcare professionals, and students in the medical field. With its prestigious Q1 rating in both Pharmacology and Pharmacology (medical) categories, and ranking in the top 4% of journals in the field, it provides cutting-edge insights into drug therapy, pharmacokinetics, and innovative treatment strategies. The journal features a wide range of articles, from original research to comprehensive reviews, all aimed at advancing knowledge and clinical practice in pharmacology. With a publication history dating back to 1960 and continuing through 2024, its commitment to excellence is evident in its robust impact factor and high visibility in the academic community. For professionals striving to stay at the forefront of pharmacological advancements, CLINICAL PHARMACOLOGY & THERAPEUTICS remains an essential platform for disseminating and accessing vital research findings.

JOURNAL OF AVIAN MEDICINE AND SURGERY

Exploring the frontiers of avian medicine and surgery.
Publisher: ASSOC AVIAN VETERINARIANSISSN: 1082-6742Frequency: 4 issues/year

JOURNAL OF AVIAN MEDICINE AND SURGERY, published by the Association of Avian Veterinarians, serves as an essential resource for professionals and researchers in the field of avian veterinary medicine. Established in 1996, the journal has consistently contributed to the understanding and advancement of medical and surgical practices in avian species, showcasing innovative research and comprehensive reviews that address the unique health challenges faced by birds. With an ISSN of 1082-6742 and an E-ISSN of 1938-2871, this journal is indexed in Scopus, ranking 13th out of 20 in the Small Animals category, placing it within the 37th percentile and exemplifying its impact in the veterinary community. Although not an Open Access journal, it is vital for advancing knowledge and improving veterinary care for avian clients. Its commitment to excellence is reflected in its designation within the Q3 quartile in both miscellaneous medicine and small animals, indicating its growing influence and relevance in the veterinary literature. The journal encourages contributions that enhance the understanding of avian health, providing a platform for ideas that will drive progress in this niche field.